Cancer
Breakthrough discovery could lead to new targeted cancer treatment
March 10, 2017Medical Communications Cancer, The Scripps Research Institute
Research conducted by The Scripps Research Institute has unearthed a potential treatment for those with prostate and breast cancer that …
Diabetes drug could be key to treating aggressive breast cancer, research suggests
March 8, 2017Research and Development Cancer, diabetes
Researchers from the Zhejiang University School of Medicine have identified that the function of metabolic enzyme AKR1B1 is key to …
New cancer drug could give hope to non-responsive patients
February 15, 2017Research and Development Cancer
A new dual action drug developed as part of a collaboration between biopharmaceutical oncology firm Almac Discovery and The Royal …
Brexit could delay key drugs to UK patients, ex-MHRA chairman claims
February 10, 2017Medical Communications, Sales and Marketing Cancer, MHRA, brexit
Former UK regulator and ex-chairman of the Medicines and Healthcare products Regulatory Agency (MHRA) Sir Alasdair Breckenridge has warned that …
Cancer rates set to rocket in women six times faster than men
February 3, 2017Medical Communications, Research and Development Cancer, Cancer Research UK, World Cancer Day
The figures emerging from research conducted by Cancer Research UK predict that rates of cancer in women will rise by …
Skin cancer-detecting AI “on par with board-certified dermatologists”
January 27, 2017Medical Communications, Research and Development AI, Cancer, skin cancer
New research has found that artificial intelligence repurposed by researchers at Stanford University to identify skin cancer in images has …
Statins revealed to potentially aid cancer treatment
January 25, 2017Research and Development Cancer, University of Kansan, statins
New research, conducted at the University of Kansas, has emerged that reveal a potential use for statins beyond their current …
Two-step treatment cuts off cancer’s backup defences
January 25, 2017Research and Development Cancer, sarcoma, washington university
New research conducted at Washington University’s School of Medicine and published in Cell Reports details a new method for fighting …
New immunotherapy-based cancer research limits cancer spread by 75%
January 12, 2017Medical Communications, Research and Development Cancer, cancer research, immunotherapy
Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the …
Research finds cancer cells spread even before tumour development
January 10, 2017Manufacturing and Production, Research and Development Cancer
Studies at the Icahn School of Medicine in New York City and the University of Regensburg in Germany have found …
New research reveals how cancer cells grow and spread through body
January 6, 2017Medical Communications Cancer, Cancer Research UK, ICR, Institute of Cancer Research, cancer research, cell movement
Research conducted by The Institute of Cancer Research (ICR), co-funded by Cancer Research UK, has discovered how cancer cells are …
New molecular-binding technique promises accelerated drug development
December 5, 2016Research and Development, Sales and Marketing Alzheimer's, Cancer, Indiana University-Purdue University Indianapolis
Researchers at the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) have claimed to have designed a new molecular …
Roche’s immunotherapy cancer drug given FDA approval
October 19, 2016Research and Development Cancer, FDA, Genentech, Roche, immunotherapy, lung cancer
Coming off the back of earlier positive news this month, Roche has revealed that their drug, Tecentriq, has been given …
FDA grants $23 million to boost research on rare diseases
October 19, 2016Research and Development Cancer, FDA, clinical trials, oncology
The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, …
IBM and Quest forge precision cancer treatment partnership
October 18, 2016Manufacturing and Production, Medical Communications Cancer, Precision Medicine, Quest, ibm, oncology
IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
